Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kathleen Clarence-Smith
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
Neurotherapeutics
Neurology
Pharmacology
Related publications
Donepezil + Chromone + Melatonin Hybrids as Promising Agents for Alzheimer’s Disease Therapy
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Effects of Cognitive-Communication Stimulation for Alzheimer’s Disease Patients Treated With Donepezil
Journal of Speech, Language, and Hearing Research
Medicine
Linguistics
Speech
Language
Hearing
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease
Neurotherapeutics
Neurology
Pharmacology
Current Understanding of Alzheimer’s Disease Diagnosis and Treatment
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Disease-Modifying Treatments for Alzheimer’s Disease
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Frontiers in Molecular Neuroscience
Molecular Neuroscience
Molecular Biology
Cellular
Are Biomarkers Valid as Surrogates for Treatment Effects in Alzheimer’s Disease?
European Neurological Review
Neurology
Risk Factors for Alzheimer’s Disease
Science Insights